Study S002742

Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window -- A Multicenter, Prospective, Open-label, Blind Endpoint, Randomized Controlled Trial（ANGEL-BAO）

ClinicalTrials.gov record

Registration

Registration: NCT06101667
Acronym: ANGEL-BAO
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: COMPLETED
Enrollment: 224
Start: 2023-11-16
Primary completion: 2026-02-25
Lead sponsor: Beijing Tiantan Hospital
Conditions: Acute Ischemic Stroke; Basilar Artery Occlusion
Interventions: DRUG:Best medical management; PROCEDURE:Endovascular treatment
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Rate of modified Rankin scale 0-3 at 90 (±14) days after randomization [90±14 days after randomization]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.